Sei Investments CO Atara Biotherapeutics, Inc. Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.31 $23,100 - $37,844	16,383 Added 103.55%	32,204 $47,000
Q2 2023 Aug 11, 2023	SELL	$1.5 - $3.04 $17,505 - $35,476	-11,670 Reduced 42.45%	15,821 $25,000
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $33,628 - $65,574	12,010 Added 77.58%	27,491 $79,000
Q4 2022 Feb 10, 2023	SELL	$2.85 - $5.18 $1,969 - $3,579	-691 Reduced 4.27%	15,481 $50,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $46,090 - $141,181	16,172 New	16,172 $61,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.